U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C30H23N5O
Molecular Weight 469.5365
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DACTOLISIB

SMILES

CN1C(=O)N(C2=C1C=NC3=CC=C(C=C23)C4=CN=C5C=CC=CC5=C4)C6=CC=C(C=C6)C(C)(C)C#N

InChI

InChIKey=JOGKUKXHTYWRGZ-UHFFFAOYSA-N
InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including: http://adisinsight.springer.com/drugs/800026094 https://www.ncbi.nlm.nih.gov/pubmed/18606717

Dactolisib is a dual inhibitor of phosphatidylinositol 3-kinase (P13K) and the downstream mammalian target of rapamycin (mTOR) by binding to the ATP-binding cleft of these enzymes (inhibitor of PI3K/Akt/mTOR cascade). It is being investigated as a possible anti-cancer cancer agent and drug against Influenza virus infections. Frequently reported adverse events included nausea, vomiting, diarrhoea, fatigue/asthenia, anaemia, and anorexia.

Originator

Curator's Comment: https://www.google.com/patents/WO2006122806A2?cl=en # Novartis

Approval Year

TargetsConditions
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.
2009 May 15
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
2011 Jul
Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells.
2011 Jun 1
The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer cell lines.
2011 Mar
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition.
2012 Apr 10
Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification.
2012 Jul
Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
2012 Oct
Synergistic induction of cell death in haematological malignancies by combined phosphoinositide-3-kinase and BET bromodomain inhibition.
2015 Jul
Patents

Sample Use Guides

400 or 300 mg twice daily
Route of Administration: Oral
IC50 doses of dactolisib for P3 and U87 glioma cells were established at 12.7 nM and 15.8 nM, respectively.
Name Type Language
DACTOLISIB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
RTB101
Code English
RTB-101
Code English
NSC-751249
Code English
dactolisib [INN]
Common Name English
2-Methyl-2-(4-{3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl}phenyl)propanenitrile
Systematic Name English
2-METHYL-2-(4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-1H-IMIDAZO(4,5-C)QUINOLIN-1-YL)PHENYL)PROPANENITRILE
Systematic Name English
BEZ-235
Code English
BEZ235
Code English
DACTOLISIB [USAN]
Common Name English
Dactolisib [WHO-DD]
Common Name English
NVP-BEZ-235
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2152
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
NCI_THESAURUS C129825
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
Code System Code Type Description
MESH
C531198
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
CAS
915019-65-7
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
SMS_ID
100000170045
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
PUBCHEM
11977753
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
FDA UNII
RUJ6Z9Y0DT
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
INN
9545
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
CHEBI
71952
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
WIKIPEDIA
BEZ235
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL1879463
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
EPA CompTox
DTXSID10238599
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
DRUG BANK
DB11651
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
USAN
AB-105
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
EVMPD
SUB183868
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
NSC
751249
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY
NCI_THESAURUS
C74072
Created by admin on Fri Dec 15 15:40:17 GMT 2023 , Edited by admin on Fri Dec 15 15:40:17 GMT 2023
PRIMARY